Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma.
Zhou D, Wang Y, Cheng H, Zhu L, Chen W, Li H, Zhang X, Xia J, Qi Y, Ma S, Zhu F, Yan Z, Qi K, Sang W, Sun H, Li D, Cao J, Li Z, Xu K.
Zhou D, et al. Among authors: zhang x.
J Infect Chemother. 2023 Feb;29(2):179-185. doi: 10.1016/j.jiac.2022.10.012. Epub 2022 Nov 8.
J Infect Chemother. 2023.
PMID: 36368473